Showing results (111-120 of 422) with videos related to
Sort By:
Pageof 43
Human Vaccines & Immunotherapeutics|February 21, 2013
Evaluation of the frequency of immunization information system use for public health researchEileen A Curran, Robert A Bednarczyk, Saad B OmerJMIR Research Protocols|April 14, 2025
Designing eHealth Interventions for Pediatric Emergency Departments: Protocol for a Usability Testing Study With Youth, Parent, and Clinician ParticipantsMari Somerville, Lori Wozney, Allyson Gallant, et al.Brain Injury|November 1, 1996
Outcome following traumatic brain injury: a comparison between 2 and 5 years after injuryJ H Olver, J L Ponsford, C A CurranProceedings. Symposium on Computer Applications in Medical Care|January 1, 1994
Homeless patients: designing a database for nursing documentationM A Curran, K E Curran, W K CodyThe Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|June 28, 2008
Lucja Frey--historical relevance and syndrome reviewJ P O'Neill, C Condron, A Curran, et al.Family Process|January 8, 2025
Benefits and burdens of daily sacrifices and commitment in same- and different-gender couples: Explorations of proximity and direction of effectsCasey J Totenhagen, Melissa A Curran, Ashley K RandallClinical Otolaryngology and Allied Sciences|August 1, 1997
Cancer of the pyriform fossa: hyperfractionated radiotherapy as a primary treatment modalityB J Conlon, M Walsh, D McShane, et al.Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumorsMichael A Curran, Welby Montalvo, Hideo Yagita, et al.Thrombosis Research|January 24, 2012
Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow deviceEric F Grabowski, Marjorie A Curran, Elizabeth M Van CottOncogene|June 28, 2016
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancerS Chouaib, M Z Noman, K Kosmatopoulos, et al.Pageof 43